患者特異的ヒト肝臓モデルを開発(Patient-specific human liver model to understand disease mechanisms)

ad

2025-12-17 マックス・プランク研究所

ドイツのマックス・プランク研究所の研究チームは、患者ごとの特性を反映したヒト肝臓モデルを開発し、肝疾患の発症メカニズム解明に向けた新たな研究基盤を提示した。このモデルは、患者由来細胞を用いて肝臓の主要な細胞構成や機能を再現するもので、従来の動物実験や一般的な細胞培養では捉えにくかった個人差や疾患特異的変化を詳細に解析できる。研究により、代謝異常や炎症反応など、肝疾患進行に関わる分子・細胞レベルの相互作用が明確になり、精密医療への応用可能性が示された。本成果は、肝疾患の新規治療法開発や薬剤評価の高度化に貢献すると期待される。

患者特異的ヒト肝臓モデルを開発(Patient-specific human liver model to understand disease mechanisms)
Human periportal assembloid, showcasing the three key cell types of the liver: portal fibroblasts (magenta), cholangiocytes (green), and hepatocyte nuclei (blue). All cell borders are delineated in white. © Lei Yuan, Sagarika Dawka, Yohan Kim, Anke Liebert et al. / Nature (2025) / MPI-CBG

<関連情報>

ヒトアセンブロイドはin vitroで門脈周囲肝組織を再現する Human assembloids recapitulate periportal liver tissue in vitro

Lei Yuan,Sagarika Dawka,Yohan Kim,Anke Liebert,Fabian Rost,Robert Arnes-Benito,Franziska Baenke,Christina Götz,David Long Hin Tsang,Andrea Schuhmann,Anna Shevchenko,Roberta Rezende de Castro,Seunghee Kim,Aleksandra Sljukic,Anna M. Dowbaj,Andrej Shevchenko,Daniel Seehofer,Dongho Choi,Georg Damm,Daniel E. Stange & Meritxell Huch
Nature  Published:17 December 2025
DOI:https://doi.org/10.1038/s41586-025-09884-1

Abstract

The development of complex multicellular human in vitro systems holds great promise for modelling disease and advancing drug discovery and tissue engineering1. In the liver, despite the identification of key signalling pathways involved in hepatic regeneration2,3, in vitro expansion of human hepatocytes directly from fresh patient tissue has not yet been achieved, limiting the possibility of modelling liver composite structures in vitro. Here we first developed human hepatocyte organoids (h-HepOrgs) from 28 different patients. Patient-derived hepatocyte organoids sustained long-term expansion of hepatocytes in vitro and maintained patient-specific gene expression and bile canaliculus features and function of the in vivo tissue. After transplantation, expanded h-HepOrgs rescued the phenotype of a mouse model of liver disease. By combining h-HepOrgs with portal mesenchyme and our previously published cholangiocyte organoids4,5,6, we generated patient-specific periportal liver assembloids that retain the histological arrangement, gene expression and cell interactions of periportal liver tissue, with cholangiocytes and mesenchyme embedded in the hepatocyte parenchyma. We leveraged this platform to model aspects of biliary fibrosis. Our human periportal liver assembloid system represents a novel in vitro platform to investigate human liver pathophysiology, accelerate drug development, enable early diagnosis and advance personalized medicine.

細胞遺伝子工学
ad
ad
Follow
ad
タイトルとURLをコピーしました